News Release

News Release

Printer Friendly Version View printer-friendly version
<< Back
Pacira Pharmaceuticals to Present at the Barclays Capital 2011 Global Healthcare Conference

PARSIPPANY, N.J., March 8, 2011 /PRNewswire via COMTEX/ -- Pacira Pharmaceuticals, Inc. (Nasdaq: PCRX), an emerging specialty pharmaceutical company, today announced that David Stack, president and chief executive officer, is scheduled to present at the Barclays Capital 2011 Global Healthcare Conference on Thursday, March 17, 2011, at 9:30 a.m. EDT being held at the Loews Miami Hotel in Miami, FL. Mr. Stack is expected to present an overview of the company.

A live audio webcast of Pacira's presentation can be accessed by visiting the investors section of the company's website at investor.pacira.com. A replay of the webcast will be archived on the Pacira website for two weeks following the presentation date.

About Pacira

Pacira Pharmaceuticals, Inc. is an emerging specialty pharmaceutical company focused on the development, manufacture, and commercialization of novel pharmaceutical products, based on its proprietary DepoFoam drug delivery technology, for use in hospitals and ambulatory surgery centers. The company's most advanced investigational product candidate, EXPAREL, a bupivacaine-based product, has completed Phase 3 clinical development for postoperative analgesia by infiltration. EXPAREL consists of bupivacaine encapsulated in DepoFoam, which is designed to address the limitations of widely used medications by enhancing their dosing and/or administration profile. Additional information about Pacira is available at http://www.pacira.com/.

Contacts:


Company Contact:

Pacira Pharmaceuticals, Inc.

James S. Scibetta, 973-254-3560

or

Investor Contact:

Pure Communications Inc.

Jennifer Beugelmans, 646-596-7473

SOURCE Pacira Pharmaceuticals, Inc.